NO20030618L - Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene - Google Patents

Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene

Info

Publication number
NO20030618L
NO20030618L NO20030618A NO20030618A NO20030618L NO 20030618 L NO20030618 L NO 20030618L NO 20030618 A NO20030618 A NO 20030618A NO 20030618 A NO20030618 A NO 20030618A NO 20030618 L NO20030618 L NO 20030618L
Authority
NO
Norway
Prior art keywords
peptide salts
preparation
pharmaceutical preparations
preparations containing
peptide
Prior art date
Application number
NO20030618A
Other languages
English (en)
Other versions
NO20030618D0 (no
Inventor
Michael Damm
Waldemar Salonek
Juergen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20030618(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20030618L publication Critical patent/NO20030618L/no
Publication of NO20030618D0 publication Critical patent/NO20030618D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO20030618A 2000-08-17 2003-02-07 Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene NO20030618D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
PCT/EP2001/009219 WO2002014347A2 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (2)

Publication Number Publication Date
NO20030618L true NO20030618L (no) 2003-02-07
NO20030618D0 NO20030618D0 (no) 2003-02-07

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030618A NO20030618D0 (no) 2000-08-17 2003-02-07 Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene

Country Status (30)

Country Link
US (1) US6780972B2 (no)
EP (1) EP1309607B1 (no)
JP (1) JP2004506647A (no)
CN (1) CN1187369C (no)
AR (1) AR030371A1 (no)
AT (1) ATE280779T1 (no)
AU (2) AU2002210439B2 (no)
BG (1) BG107612A (no)
BR (1) BR0113296A (no)
CA (1) CA2355573A1 (no)
CZ (1) CZ2003688A3 (no)
DE (2) DE10040700A1 (no)
DK (1) DK1309607T3 (no)
EE (1) EE200300065A (no)
ES (1) ES2230371T3 (no)
HK (1) HK1058366A1 (no)
HU (1) HUP0300738A3 (no)
IL (1) IL154150A0 (no)
MX (1) MXPA03001448A (no)
NO (1) NO20030618D0 (no)
NZ (1) NZ524023A (no)
PL (1) PL204496B1 (no)
PT (1) PT1309607E (no)
RU (1) RU2266296C2 (no)
SI (1) SI1309607T1 (no)
SK (1) SK3032003A3 (no)
TW (1) TWI236910B (no)
UA (1) UA74005C2 (no)
WO (1) WO2002014347A2 (no)
ZA (1) ZA200300777B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800A (zh) * 2020-09-22 2022-03-29 深圳市星银医药有限公司 一种双羟萘酸多肽药物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
DE3165535D1 (en) * 1980-06-02 1984-09-20 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
JP2944419B2 (ja) * 1993-05-10 1999-09-06 ノバルティス アクチエンゲゼルシャフト 持続性遊離組成物中の薬理学的活性成分の安定
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
US6740634B1 (en) * 1998-01-16 2004-05-25 Takeda Chemical Industries, Ltd. Sustained release compositions, process for producing the same and utilization thereof

Also Published As

Publication number Publication date
CN1187369C (zh) 2005-02-02
SI1309607T1 (en) 2005-02-28
EP1309607B1 (de) 2004-10-27
TWI236910B (en) 2005-08-01
NZ524023A (en) 2004-11-26
DE50104316D1 (de) 2004-12-02
BR0113296A (pt) 2003-07-15
CN1447817A (zh) 2003-10-08
WO2002014347A3 (de) 2002-08-08
HUP0300738A3 (en) 2004-08-30
WO2002014347A2 (de) 2002-02-21
EE200300065A (et) 2004-12-15
AR030371A1 (es) 2003-08-20
EP1309607A2 (de) 2003-05-14
UA74005C2 (en) 2005-10-17
ATE280779T1 (de) 2004-11-15
CA2355573A1 (en) 2003-02-22
HK1058366A1 (en) 2004-05-14
MXPA03001448A (es) 2004-12-13
ES2230371T3 (es) 2005-05-01
IL154150A0 (en) 2003-07-31
SK3032003A3 (en) 2004-05-04
DE10040700A1 (de) 2002-02-28
US20020198146A1 (en) 2002-12-26
US6780972B2 (en) 2004-08-24
PT1309607E (pt) 2005-02-28
AU2002210439B2 (en) 2005-10-20
AU1043902A (en) 2002-02-25
PL359495A1 (en) 2004-08-23
CZ2003688A3 (cs) 2004-03-17
RU2003107560A (ru) 2005-01-27
JP2004506647A (ja) 2004-03-04
HUP0300738A2 (hu) 2003-09-29
ZA200300777B (en) 2003-09-18
NO20030618D0 (no) 2003-02-07
PL204496B1 (pl) 2010-01-29
DK1309607T3 (da) 2005-01-17
RU2266296C2 (ru) 2005-12-20
BG107612A (bg) 2003-12-31

Similar Documents

Publication Publication Date Title
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO991130D0 (no) Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav
NO20032726D0 (no) Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
DK1320531T3 (da) Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
NO20010277L (no) Benzocykloheptener, fremgangsmÕte for fremstilling derav, farmasøytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
NO20005430D0 (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmÕter for fremstilling av disse, medisinske preparater inneholdende dem, og mellomprodukter
NO994671D0 (no) Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika
NO20021398D0 (no) 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
NO984309D0 (no) Nye imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse
DK1117661T3 (da) Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO20030618L (no) Fremgangsmåte til fremstilling av peptidsalter, deres anvendelse, og farmasöytiske preparater som inneholder disse peptidsaltene
NO20016404D0 (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1165528T3 (da) Hidtil ukendte morpholinoderivater, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK0858459T3 (da) Nye sure pyrazolforbindelser, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler, deres nye anvendelse og farmaceutiske præparater med indhold deraf
DK1215213T3 (da) Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
NO20002483D0 (no) Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse
NO20013141D0 (no) Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse
NO20032959L (no) Derivater av etoposid og analoger, samt farmasöytiske preparater inneholdende disse
NO20024802L (no) Terapeutisk anvendbare nye salter av CCK-inhibitorer, fremgangsmÕte for fremstilling derav og farmasöytiske preparaterinneholdende disse